HK1204290A1 - 用於治療腹瀉的物質和方法 - Google Patents

用於治療腹瀉的物質和方法

Info

Publication number
HK1204290A1
HK1204290A1 HK15104949.7A HK15104949A HK1204290A1 HK 1204290 A1 HK1204290 A1 HK 1204290A1 HK 15104949 A HK15104949 A HK 15104949A HK 1204290 A1 HK1204290 A1 HK 1204290A1
Authority
HK
Hong Kong
Prior art keywords
materials
methods
treating diarrhea
diarrhea
treating
Prior art date
Application number
HK15104949.7A
Other languages
English (en)
Inventor
Sadasivan Vidyasagar
Paul Okunieff
Lurong Zhang
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Publication of HK1204290A1 publication Critical patent/HK1204290A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
HK15104949.7A 2012-02-08 2015-05-26 用於治療腹瀉的物質和方法 HK1204290A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261596480P 2012-02-08 2012-02-08
PCT/US2013/025294 WO2013119917A1 (en) 2012-02-08 2013-02-08 Materials and methods for treating diarrhea

Publications (1)

Publication Number Publication Date
HK1204290A1 true HK1204290A1 (zh) 2015-11-13

Family

ID=48948047

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104949.7A HK1204290A1 (zh) 2012-02-08 2015-05-26 用於治療腹瀉的物質和方法

Country Status (15)

Country Link
US (3) US20140377374A1 (zh)
EP (1) EP2812007B1 (zh)
JP (1) JP6084238B2 (zh)
KR (2) KR102262179B1 (zh)
CN (1) CN104093410B (zh)
AP (1) AP3941A (zh)
AU (1) AU2013216871B2 (zh)
BR (1) BR112014019350B1 (zh)
CA (1) CA2863388C (zh)
EA (1) EA034014B1 (zh)
ES (1) ES2862392T3 (zh)
HK (1) HK1204290A1 (zh)
IN (1) IN2014DN06737A (zh)
MX (1) MX368543B (zh)
WO (1) WO2013119917A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170084354A (ko) 2010-09-24 2017-07-19 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 위장 기능을 증진시키기 위한 물질 및 방법
MX361647B (es) 2013-03-11 2018-12-13 Univ Florida Materiales y métodos para mejorar la función pulmonar y para la prevención y/o tratamiento de complicaciones pulmonares inducidas por radiación.
EP3616689A1 (en) * 2014-11-24 2020-03-04 Entrinsic Health Solutions, Inc. Amino acid compositions for the treatment of symptoms of disease
CA3039514C (en) 2016-10-04 2022-01-25 University Of Florida Research Foundation, Incorporated Amino acid compositions and uses thereof
WO2019070753A1 (en) * 2017-10-02 2019-04-11 University Of Florida Research Foundation, Incorporated AMINO ACID COMPOSITIONS AND METHODS FOR TREATING DIARRHEA
JP2023531874A (ja) * 2020-06-02 2023-07-26 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド 下痢を治療するための製剤および方法
WO2022006397A1 (en) * 2020-07-02 2022-01-06 University Of Florida Research Foundation, Incorporated Formulations for promoting hydration and methods of use thereof
WO2022251624A1 (en) * 2021-05-28 2022-12-01 The Coca-Cola Company Amino acid hydration formulation and method of use
CN115531363B (zh) * 2021-06-30 2024-03-29 中国科学技术大学 预防、抑制或治疗轮状病毒感染的药物组合物及其用途
US11878073B1 (en) * 2022-09-20 2024-01-23 Entrinsic, LLC Generation of hydration-targeted formulations and methods of use therein

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290538A (en) * 1988-12-22 1994-03-01 Skrezek Christian Nephro protective infusion solutions
JP3301646B2 (ja) * 1993-03-19 2002-07-15 シスメックス株式会社 幼若細胞測定用試薬
KR19980703876A (ko) * 1995-04-14 1998-12-05 스티븐 엘. 허스트 분산성이 개선된 분말화된 약학적 조성물
JP4255656B2 (ja) * 2001-09-17 2009-04-15 株式会社メニコン 眼科用液剤及びコンタクトレンズ用液剤
US20030143293A1 (en) * 2002-01-31 2003-07-31 Sergei Shushunov Compositions and methods for treating diarrhea
JP2004123642A (ja) * 2002-10-04 2004-04-22 Shimizu Pharmaceutical Co Ltd 電解質組成物
DK175877B1 (da) * 2002-11-11 2005-05-09 Pharmalett As Præparater til anvendelse som terapeutisk middel
US20050100637A1 (en) * 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
GB0503337D0 (en) * 2005-02-17 2005-03-23 Glaxosmithkline Biolog Sa Compositions
JP4811576B2 (ja) * 2005-03-31 2011-11-09 味の素株式会社 水分電解質補給飲料
JP4512013B2 (ja) * 2005-09-07 2010-07-28 和光堂株式会社 液体飲料組成物及びその製造方法
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
KR20170084354A (ko) * 2010-09-24 2017-07-19 유니버시티 오브 플로리다 리서치 파운데이션, 인크. 위장 기능을 증진시키기 위한 물질 및 방법
MX361647B (es) * 2013-03-11 2018-12-13 Univ Florida Materiales y métodos para mejorar la función pulmonar y para la prevención y/o tratamiento de complicaciones pulmonares inducidas por radiación.

Also Published As

Publication number Publication date
CA2863388A1 (en) 2013-08-15
EP2812007A1 (en) 2014-12-17
BR112014019350A8 (pt) 2017-07-11
ES2862392T3 (es) 2021-10-07
BR112014019350A2 (zh) 2017-06-20
AU2013216871B2 (en) 2017-08-17
CN104093410B (zh) 2018-04-27
AU2013216871A1 (en) 2014-09-11
CA2863388C (en) 2020-11-17
US20150297636A1 (en) 2015-10-22
MX368543B (es) 2019-10-07
EP2812007B1 (en) 2020-12-30
EP2812007A4 (en) 2015-09-09
JP2015506981A (ja) 2015-03-05
KR20200105525A (ko) 2020-09-07
KR102262179B1 (ko) 2021-06-07
MX2014009557A (es) 2014-11-10
CN104093410A (zh) 2014-10-08
BR112014019350B1 (pt) 2020-09-24
EA034014B1 (ru) 2019-12-19
US20140377374A1 (en) 2014-12-25
US20210299076A1 (en) 2021-09-30
WO2013119917A1 (en) 2013-08-15
KR20140120941A (ko) 2014-10-14
IN2014DN06737A (zh) 2015-05-22
EA201400827A1 (ru) 2014-12-30
AP2014007916A0 (en) 2014-09-30
JP6084238B2 (ja) 2017-02-22
AP3941A (en) 2016-12-16

Similar Documents

Publication Publication Date Title
HK1214521A1 (zh) 用於治療蛋白質病的組合物和方法
GB2535435B (en) Methods for treating lignocellulosic materials
HK1204290A1 (zh) 用於治療腹瀉的物質和方法
EP2919788A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF SCHIZOPHRENIA
EP2907593A4 (en) METHOD FOR TREATING A USED VOIDABLE ARTICLE
EP2919759A4 (en) MATERIALS AND METHODS FOR THE TREATMENT OF GLIOBLASTOMES
IL273377A (en) Product and method for treating diarrhea
EP2928560A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF HIV-ASSOCIATED DIARRHEA
HK1206352A1 (zh) 治療實體瘤的手段和方法
EP2948138A4 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF SPASTIC HYPERTONIA
EP2938415A4 (en) MATERIALS AND METHOD
EP2825693A4 (en) METHOD AND MATERIALS FOR THE TREATMENT OF CANCER
EP2803396A4 (en) SAMPLE CONCENTRATION CONTAINER AND SAMPLE CONCENTRATION METHOD THEREWITH
GB201218747D0 (en) Milling and drying apparatus and method
ZA201406172B (en) Compounds and methods for treating leukemia
GB201222820D0 (en) Woolscouring method and composition
HK1209040A1 (zh) 用於治療前庭毒性的方法
GB201213778D0 (en) Process and dressng
GB201206859D0 (en) Method and composition
ZA201500172B (en) Plant-disease-control composition and plant-disease-control method
GB201222736D0 (en) Composition and process
EP2812487A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF MEDIA
GB201222810D0 (en) Woolscouring method and composition
EP2838532A4 (en) PROCESS FOR TREATING SCLERRODERY
GB201204512D0 (en) Method and composition